speb/financial-data huggingface dataset:
MBLY cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 506000000.00
MBLY cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 506000000.00
MBLY income_statement (annual, 2024-12-31) — Diluted Average Shares: 809000000.00
MBLY income_statement (annual, 2024-12-31) — Diluted EPS: -3.82
MBLY income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -3090000000.00
MBLY balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 4000000.00
MBLY income_statement (annual, 2024-12-31) — EBIT: -530000000.00
MBLY income_statement (annual, 2024-12-31) — EBITDA: -24000000.00
MBLY cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -2000000.00
MBLY balance_sheet (annual, 2024-12-31) — Employee Benefits: 62000000.00
MBLY cash_flow (annual, 2024-12-31) — End Cash Position: 1438000000.00
MBLY cash_flow (annual, 2024-12-31) — Financing Cash Flow: -66000000.00
MBLY balance_sheet (annual, 2024-12-31) — Finished Goods: 379000000.00
MBLY cash_flow (annual, 2024-12-31) — Free Cash Flow: 319000000.00
MBLY cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -3000000.00
MBLY balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2000000.00
MBLY income_statement (annual, 2024-12-31) — General And Administrative Expense: 70000000.00
MBLY balance_sheet (annual, 2024-12-31) — Goodwill: 8200000000.00
MBLY balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 9809000000.00
MBLY balance_sheet (annual, 2024-12-31) — Gross PPE: 586000000.00
MBLY income_statement (annual, 2024-12-31) — Gross Profit: 741000000.00
MBLY income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 2695000000.00
MBLY income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
MBLY cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 21000000.00
MBLY cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 1000000.00
MBLY income_statement (annual, 2024-12-31) — Interest Expense: 0.00
MBLY income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 0.00
MBLY income_statement (annual, 2024-12-31) — Interest Income: 0.00
MBLY income_statement (annual, 2024-12-31) — Interest Income Non Operating: 0.00
MBLY cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
MBLY balance_sheet (annual, 2024-12-31) — Inventory: 415000000.00
MBLY balance_sheet (annual, 2024-12-31) — Invested Capital: 12087000000.00
MBLY cash_flow (annual, 2024-12-31) — Investing Cash Flow: -120000000.00
MBLY cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
MBLY balance_sheet (annual, 2024-12-31) — Leases: 44000000.00
MBLY balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 221000000.00
MBLY cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
MBLY cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 2000000.00
MBLY income_statement (annual, 2024-12-31) — Net Income: -3090000000.00
MBLY income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -3090000000.00
MBLY income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -3090000000.00
MBLY income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3090000000.00
MBLY income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3090000000.00
MBLY cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -3090000000.00
MBLY income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -3090000000.00
MBLY income_statement (annual, 2024-12-31) — Net Interest Income: 62000000.00
MBLY cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -39000000.00
MBLY income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 62000000.00
MBLY cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -66000000.00
MBLY cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -50000000.00
MBLY balance_sheet (annual, 2024-12-31) — Net PPE: 458000000.00
MBLY cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -81000000.00
MBLY balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2278000000.00
MBLY balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 47000000.00
MBLY balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 47000000.00
MBLY income_statement (annual, 2024-12-31) — Normalized EBITDA: 2671000000.00
MBLY income_statement (annual, 2024-12-31) — Normalized Income: -456985000.00
MBLY cash_flow (annual, 2024-12-31) — Operating Cash Flow: 400000000.00
MBLY cash_flow (annual, 2024-12-31) — Operating Gains Losses: -1000000.00
MBLY income_statement (annual, 2024-12-31) — Operating Income: -530000000.00
MBLY income_statement (annual, 2024-12-31) — Operating Revenue: 1654000000.00
MBLY balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 811726477.00
MBLY balance_sheet (annual, 2024-12-31) — Other Current Assets: 121000000.00
MBLY balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 34000000.00
MBLY balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 2000000.00
MBLY income_statement (annual, 2024-12-31) — Other Gand A: 70000000.00
MBLY income_statement (annual, 2024-12-31) — Other Income Expense: -2695000000.00
MBLY income_statement (quarterly, 2024-12-31) — Other Income Expense: 0.00
MBLY balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1609000000.00
MBLY balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 138000000.00
MBLY balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 50000000.00
MBLY balance_sheet (annual, 2024-12-31) — Payables: 194000000.00
MBLY balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 194000000.00
MBLY balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 105000000.00
MBLY income_statement (annual, 2024-12-31) — Pretax Income: -3163000000.00
MBLY balance_sheet (annual, 2024-12-31) — Properties: 0.00
MBLY cash_flow (annual, 2024-12-31) — Purchase Of Investment: -62000000.00
MBLY cash_flow (annual, 2024-12-31) — Purchase Of PPE: -81000000.00
MBLY balance_sheet (annual, 2024-12-31) — Raw Materials: 35000000.00
MBLY balance_sheet (annual, 2024-12-31) — Receivables: 212000000.00
MBLY income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 913000000.00
MBLY income_statement (annual, 2024-12-31) — Reconciled Depreciation: 506000000.00
MBLY cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
MBLY income_statement (annual, 2024-12-31) — Research And Development: 1083000000.00
MBLY balance_sheet (annual, 2024-12-31) — Retained Earnings: -3060000000.00
MBLY cash_flow (annual, 2024-12-31) — Sale Of Investment: 23000000.00
MBLY income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 118000000.00
MBLY income_statement (annual, 2024-12-31) — Selling General And Administration: 188000000.00
MBLY balance_sheet (annual, 2024-12-31) — Share Issued: 811726477.00
MBLY income_statement (annual, 2024-12-31) — Special Income Charges: -2695000000.00
MBLY income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
MBLY cash_flow (annual, 2024-12-31) — Stock Based Compensation: 279000000.00
MBLY balance_sheet (annual, 2024-12-31) — Stockholders Equity: 12087000000.00
MBLY balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2278000000.00
MBLY income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -61985000.00
MBLY income_statement (annual, 2024-12-31) — Tax Provision: -73000000.00
MBLY income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.02
MBLY balance_sheet (annual, 2024-12-31) — Total Assets: 12579000000.00
MBLY balance_sheet (annual, 2024-12-31) — Total Capitalization: 12087000000.00
MBLY balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 12087000000.00
MBLY income_statement (annual, 2024-12-31) — Total Expenses: 2184000000.00
MBLY balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 492000000.00
MBLY balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 10405000000.00
MBLY balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 159000000.00
MBLY income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -3225000000.00
MBLY income_statement (annual, 2024-12-31) — Total Other Finance Cost: -62000000.00
MBLY income_statement (annual, 2024-12-31) — Total Unusual Items: -2695000000.00
MBLY income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
MBLY income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -2695000000.00
MBLY income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MBLY balance_sheet (annual, 2024-12-31) — Work In Process: 1000000.00
MBLY balance_sheet (annual, 2024-12-31) — Working Capital: 1841000000.00
MBLY income_statement (quarterly, 2025-03-31) — +Operating Expense: 324000000.00
MBLY income_statement (quarterly, 2025-03-31) — +Total Revenue: 438000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 150000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 217000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -145000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 15204000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 111000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 111000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
MBLY income_statement (quarterly, 2025-03-31) — Basic Average Shares: 812000000.00
MBLY income_statement (quarterly, 2025-03-31) — Basic EPS: -0.13
MBLY cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1438000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 317000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -14000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Capital Stock: 8000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1512000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1512000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 3000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -25000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 109000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -36000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 0.00
MBLY cash_flow (quarterly, 2025-03-31) — Change In Inventory: 51000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 18000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -3000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Change In Payable: -36000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -36000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Change In Receivables: -5000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 25000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -5000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Changes In Cash: 87000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Common Stock: 8000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 12049000000.00
MBLY income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 231000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Current Assets: 2215000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 290000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -6000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Deferred Tax: -6000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Depreciation: 18000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 129000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 129000000.00
MBLY income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 812000000.00
MBLY income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.13
MBLY income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -102000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 5000000.00
MBLY income_statement (quarterly, 2025-03-31) — EBIT: -117000000.00
MBLY income_statement (quarterly, 2025-03-31) — EBITDA: 12000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 2000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 63000000.00
MBLY cash_flow (quarterly, 2025-03-31) — End Cash Position: 1527000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 3000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Finished Goods: 334000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 95000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1000000.00
MBLY income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 18000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Goodwill: 8200000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 9698000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Gross PPE: 595000000.00
MBLY income_statement (quarterly, 2025-03-31) — Gross Profit: 207000000.00
MBLY income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
MBLY balance_sheet (quarterly, 2025-03-31) — Inventory: 364000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Invested Capital: 12049000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -25000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Leases: 45000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 233000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
MBLY cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -2000000.00
MBLY income_statement (quarterly, 2025-03-31) — Net Income: -102000000.00
MBLY income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -102000000.00
MBLY income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -102000000.00
MBLY income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -102000000.00
MBLY income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -102000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -102000000.00
MBLY income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -102000000.00
MBLY income_statement (quarterly, 2025-03-31) — Net Interest Income: 18000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -11000000.00
MBLY income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 18000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 3000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Net PPE: 450000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -14000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2351000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 41000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 41000000.00
MBLY income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 12000000.00
MBLY income_statement (quarterly, 2025-03-31) — Normalized Income: -102000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 109000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2000000.00
MBLY income_statement (quarterly, 2025-03-31) — Operating Income: -117000000.00
MBLY income_statement (quarterly, 2025-03-31) — Operating Revenue: 438000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 811996663.00
MBLY balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 122000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 31000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1000000.00
MBLY income_statement (quarterly, 2025-03-31) — Other Gand A: 18000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1498000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 135000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 55000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Payables: 155000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 155000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 104000000.00
MBLY income_statement (quarterly, 2025-03-31) — Pretax Income: -99000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
MBLY cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
MBLY cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -25000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -14000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Raw Materials: 30000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Receivables: 217000000.00
MBLY income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 231000000.00
MBLY income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 129000000.00
MBLY income_statement (quarterly, 2025-03-31) — Research And Development: 275000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -3162000000.00
MBLY cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 14000000.00
MBLY income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 31000000.00
MBLY income_statement (quarterly, 2025-03-31) — Selling General And Administration: 49000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Share Issued: 811996663.00
MBLY income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
MBLY cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 65000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 12049000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2351000000.00
MBLY income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MBLY income_statement (quarterly, 2025-03-31) — Tax Provision: 3000000.00
MBLY income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
MBLY balance_sheet (quarterly, 2025-03-31) — Total Assets: 12498000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 12049000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 12049000000.00
MBLY income_statement (quarterly, 2025-03-31) — Total Expenses: 555000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 449000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 10283000000.00
MBLY balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 159000000.00
MBLY income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -117000000.00
MBLY income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -18000000.00
MBLY income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
MBLY income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MBLY balance_sheet (quarterly, 2025-03-31) — Work In Process: 0.00
MBLY balance_sheet (quarterly, 2025-03-31) — Working Capital: 1925000000.00
MBLY income_statement (quarterly, 2025-06-30) — +Operating Expense: 326000000.00
MBLY income_statement (quarterly, 2025-06-30) — +Total Revenue: 506000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 199000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 217000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -163000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 15270000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 111000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 111000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
MBLY income_statement (quarterly, 2025-06-30) — Basic Average Shares: 812000000.00
MBLY income_statement (quarterly, 2025-06-30) — Basic EPS: -0.08
MBLY cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1527000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 319000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -14000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Capital Stock: 8000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1709000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1709000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -14000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 213000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 40000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 17000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Change In Inventory: 39000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -8000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 2000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Change In Payable: 40000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 57000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Change In Receivables: 0.00
MBLY cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 90000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 0.00
MBLY cash_flow (quarterly, 2025-06-30) — Changes In Cash: 196000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Common Stock: 8000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 12066000000.00
MBLY income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 254000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Current Assets: 2397000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 347000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -5000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Deferred Tax: -5000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Depreciation: 18000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 129000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 129000000.00
MBLY income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 812000000.00
MBLY income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.08
MBLY income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -67000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 4000000.00
MBLY income_statement (quarterly, 2025-06-30) — EBIT: -74000000.00
MBLY income_statement (quarterly, 2025-06-30) — EBITDA: 55000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 6000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 69000000.00
MBLY cash_flow (quarterly, 2025-06-30) — End Cash Position: 1729000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -3000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Finished Goods: 300000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 199000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 17000000.00
MBLY income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 19000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Goodwill: 8200000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 9587000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Gross PPE: 617000000.00
MBLY income_statement (quarterly, 2025-06-30) — Gross Profit: 252000000.00
MBLY income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
MBLY balance_sheet (quarterly, 2025-06-30) — Inventory: 325000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Invested Capital: 12066000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -14000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Leases: 48000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 250000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
MBLY cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -6000000.00
MBLY income_statement (quarterly, 2025-06-30) — Net Income: -67000000.00
MBLY income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -67000000.00
MBLY income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -67000000.00
MBLY income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -67000000.00
MBLY income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -67000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -67000000.00
MBLY income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -67000000.00
MBLY income_statement (quarterly, 2025-06-30) — Net Interest Income: 13000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
MBLY income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 13000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Net PPE: 454000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -14000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2479000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 36000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 36000000.00
MBLY income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 55000000.00
MBLY income_statement (quarterly, 2025-06-30) — Normalized Income: -67000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 213000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -7000000.00
MBLY income_statement (quarterly, 2025-06-30) — Operating Income: -74000000.00
MBLY income_statement (quarterly, 2025-06-30) — Operating Revenue: 506000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 815079323.00
MBLY balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 146000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 29000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 17000000.00
MBLY income_statement (quarterly, 2025-06-30) — Other Gand A: 19000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1387000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 140000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 60000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Payables: 203000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 203000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 115000000.00
MBLY income_statement (quarterly, 2025-06-30) — Pretax Income: -61000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
MBLY cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
MBLY cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -19000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -14000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Raw Materials: 25000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Receivables: 217000000.00
MBLY income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 254000000.00
MBLY income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 129000000.00
MBLY income_statement (quarterly, 2025-06-30) — Research And Development: 282000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -3229000000.00
MBLY cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 19000000.00
MBLY income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 25000000.00
MBLY income_statement (quarterly, 2025-06-30) — Selling General And Administration: 44000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Share Issued: 815079323.00
MBLY income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
MBLY cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 69000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 12066000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2479000000.00
MBLY income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MBLY income_statement (quarterly, 2025-06-30) — Tax Provision: 6000000.00
MBLY income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.23
MBLY balance_sheet (quarterly, 2025-06-30) — Total Assets: 12578000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 12066000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 12066000000.00
MBLY income_statement (quarterly, 2025-06-30) — Total Expenses: 580000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 512000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 10181000000.00
MBLY balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 165000000.00
MBLY income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -74000000.00
MBLY income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -13000000.00
MBLY income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
MBLY income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
MBLY balance_sheet (quarterly, 2025-06-30) — Work In Process: 0.00
MBLY balance_sheet (quarterly, 2025-06-30) — Working Capital: 2050000000.00
MBLY income_statement (quarterly, 2025-09-30) — +Operating Expense: 352000000.00
MBLY income_statement (quarterly, 2025-09-30) — +Total Revenue: 504000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 211000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 201000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -182000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 15240000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 111000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 111000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
MBLY income_statement (quarterly, 2025-09-30) — Basic Average Shares: 814000000.00
MBLY income_statement (quarterly, 2025-09-30) — Basic EPS: -0.12
MBLY cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1729000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 320000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -24000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Capital Stock: 8000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1749000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1749000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -102000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -25000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 167000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 18000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 15000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Change In Inventory: 7000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 2000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 7000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Change In Payable: 18000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 33000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Change In Receivables: 16000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 65000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 16000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Changes In Cash: 40000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Common Stock: 8000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 11935000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -100000000.00
MBLY income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 261000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Current Assets: 2416000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 374000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -5000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Deferred Tax: -5000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Depreciation: 18000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 129000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 129000000.00
MBLY income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 814000000.00
MBLY income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.12
MBLY income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -96000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 4000000.00
MBLY income_statement (quarterly, 2025-09-30) — EBIT: -109000000.00
MBLY income_statement (quarterly, 2025-09-30) — EBITDA: 20000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 0.00
MBLY balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 74000000.00
MBLY cash_flow (quarterly, 2025-09-30) — End Cash Position: 1769000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -102000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Finished Goods: 296000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 143000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 12000000.00
MBLY income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 19000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Goodwill: 8200000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 9476000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Gross PPE: 635000000.00
MBLY income_statement (quarterly, 2025-09-30) — Gross Profit: 243000000.00
MBLY income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
MBLY cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 4000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Inventory: 318000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Invested Capital: 11935000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -25000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Leases: 51000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 264000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -100000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 0.00
MBLY income_statement (quarterly, 2025-09-30) — Net Income: -96000000.00
MBLY income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -96000000.00
MBLY income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -96000000.00
MBLY income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -96000000.00
MBLY income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -96000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -96000000.00
MBLY income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -96000000.00
MBLY income_statement (quarterly, 2025-09-30) — Net Interest Income: 17000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1000000.00
MBLY income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 17000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Net PPE: 453000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -24000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2459000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 32000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 32000000.00
MBLY income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 20000000.00
MBLY income_statement (quarterly, 2025-09-30) — Normalized Income: -96000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 167000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 1000000.00
MBLY income_statement (quarterly, 2025-09-30) — Operating Income: -109000000.00
MBLY income_statement (quarterly, 2025-09-30) — Operating Revenue: 504000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 813773953.00
MBLY balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 148000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 34000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 12000000.00
MBLY income_statement (quarterly, 2025-09-30) — Other Gand A: 19000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1276000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 135000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 65000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Payables: 215000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 215000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 125000000.00
MBLY income_statement (quarterly, 2025-09-30) — Pretax Income: -92000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
MBLY cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -35000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -24000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Raw Materials: 21000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Receivables: 201000000.00
MBLY income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 261000000.00
MBLY income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 129000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -100000000.00
MBLY income_statement (quarterly, 2025-09-30) — Research And Development: 304000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -3325000000.00
MBLY cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 34000000.00
MBLY income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 29000000.00
MBLY income_statement (quarterly, 2025-09-30) — Selling General And Administration: 48000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Share Issued: 813773953.00
MBLY income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
MBLY cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 72000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 11935000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2459000000.00
MBLY income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MBLY income_statement (quarterly, 2025-09-30) — Tax Provision: 4000000.00
MBLY income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
MBLY balance_sheet (quarterly, 2025-09-30) — Total Assets: 12480000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 11935000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 11935000000.00
MBLY income_statement (quarterly, 2025-09-30) — Total Expenses: 613000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 545000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 10064000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 171000000.00
MBLY income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -109000000.00
MBLY income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -17000000.00
MBLY income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
MBLY income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
MBLY balance_sheet (quarterly, 2025-09-30) — Work In Process: 1000000.00
MBLY balance_sheet (quarterly, 2025-09-30) — Working Capital: 2042000000.00
MBLY income_statement (annual, 2025-12-31) — +Operating Expense: 1344000000.00
MBLY income_statement (quarterly, 2025-12-31) — +Operating Expense: 342000000.00
MBLY income_statement (annual, 2025-12-31) — +Total Revenue: 1894000000.00
MBLY income_statement (quarterly, 2025-12-31) — +Total Revenue: 446000000.00
MBLY balance_sheet (annual, 2025-12-31) — Accounts Payable: 228000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 228000000.00
MBLY balance_sheet (annual, 2025-12-31) — Accounts Receivable: 131000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 131000000.00
MBLY balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -171000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -171000000.00
MBLY balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 15308000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 15308000000.00
MBLY cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 443000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 110000000.00
MBLY cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 443000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 110000000.00
MBLY cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
MBLY cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
MBLY income_statement (annual, 2025-12-31) — Basic Average Shares: 813000000.00
MBLY income_statement (quarterly, 2025-12-31) — Basic Average Shares: 814000000.00
MBLY income_statement (annual, 2025-12-31) — Basic EPS: -0.48
MBLY income_statement (quarterly, 2025-12-31) — Basic EPS: -0.16
MBLY cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1438000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1769000000.00
MBLY balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 322000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 322000000.00
MBLY cash_flow (annual, 2025-12-31) — Capital Expenditure: -79000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -27000000.00
MBLY balance_sheet (annual, 2025-12-31) — Capital Stock: 8000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Capital Stock: 8000000.00
MBLY balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1836000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1836000000.00
MBLY balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1836000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1836000000.00
MBLY cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -106000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4000000.00
MBLY cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -91000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -27000000.00
MBLY cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 602000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 113000000.00
MBLY cash_flow (annual, 2025-12-31) — Change In Account Payable: 26000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 4000000.00
MBLY cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 52000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 20000000.00
MBLY cash_flow (annual, 2025-12-31) — Change In Inventory: 89000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Change In Inventory: -8000000.00
MBLY cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -29000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -41000000.00
MBLY cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 5000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1000000.00
MBLY cash_flow (annual, 2025-12-31) — Change In Payable: 26000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Change In Payable: 4000000.00
MBLY cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 78000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 24000000.00
MBLY cash_flow (annual, 2025-12-31) — Change In Receivables: 81000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Change In Receivables: 70000000.00
MBLY cash_flow (annual, 2025-12-31) — Change In Working Capital: 224000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 44000000.00
MBLY cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 81000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 70000000.00
MBLY cash_flow (annual, 2025-12-31) — Changes In Cash: 405000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Changes In Cash: 82000000.00
MBLY balance_sheet (annual, 2025-12-31) — Common Stock: 8000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Common Stock: 8000000.00
MBLY balance_sheet (annual, 2025-12-31) — Common Stock Equity: 11881000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 11881000000.00
MBLY cash_flow (annual, 2025-12-31) — Common Stock Payments: -100000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
MBLY income_statement (annual, 2025-12-31) — Cost Of Revenue: 990000000.00
MBLY income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 244000000.00
MBLY balance_sheet (annual, 2025-12-31) — Current Assets: 2478000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Current Assets: 2478000000.00
MBLY balance_sheet (annual, 2025-12-31) — Current Liabilities: 406000000.00
MBLY balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 406000000.00
MBLY cash_flow (annual, 2025-12-31) — Deferred Income Tax: -15000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 1000000.00
MBLY cash_flow (annual, 2025-12-31) — Deferred Tax: -15000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Deferred Tax: 1000000.00
MBLY cash_flow (annual, 2025-12-31) — Depreciation: 74000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Depreciation: 20000000.00
MBLY cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 517000000.00
MBLY cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 130000000.00
MBLY cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 517000000.00